Analyst Ratings for Trevi Therapeutics (TRVI)
TRVI Rating Summary
TRVI Price Target Summary
- Highest: $30.00 (Stifel)
- Lowest: $20.00 (Morgan Stanley)
- Average: $23.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$23.67 (+37.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$23.67 (+37.5%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/13/2025 | Leerink » Updated 4/21/2026 |
Roanna Ruiz | New Coverage | Outperform (N/A) |
25.00 (21.00) |
11.85 (17.21) |
45.23% | Details |
| 8/21/2025 | Morgan Stanley » Updated 5/6/2026 |
Judah Frommer | New Coverage | Overweight (N/A) |
20.00 (18.00) |
7.32 (17.21) |
135.11% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
